First Bank & Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.22M | Buy |
20,753
+626
| +3% | +$135K | 0.77% | 26 |
|
|
2026
Q1 | $4.38M | Sell |
20,127
-287
| -1% | -$63.7K | 0.71% | 32 |
|
|
2025
Q4 | $4.66M | Sell |
20,414
-186
| -0.9% | -$42.4K | 0.76% | 22 |
|
|
2025
Q3 | $4.77M | Buy |
20,600
+1,564
| +8% | +$318K | 0.8% | 20 |
|
|
2025
Q2 | $3.53M | Buy |
19,036
+890
| +5% | +$165K | 0.63% | 36 |
|
|
2025
Q1 | $3.8M | Buy |
18,146
+958
| +6% | +$186K | 0.74% | 32 |
|
|
2024
Q4 | $3.05M | Buy |
17,188
+534
| +3% | +$98.2K | 0.59% | 40 |
|
|
2024
Q3 | $3.29M | Sell |
16,654
-174
| -1% | -$32.5K | 0.62% | 42 |
|
|
2024
Q2 | $2.89M | Sell |
16,828
-1,978
| -11% | -$328K | 0.59% | 38 |
|
|
2024
Q1 | $3.42M | Buy |
18,806
+681
| +4% | +$117K | 0.71% | 29 |
|
|
2023
Q4 | $2.81M | Buy |
18,125
+68
| +0.4% | +$9.91K | 0.68% | 34 |
|
|
2023
Q3 | $2.69M | Sell |
18,057
-126
| -0.7% | -$18.5K | 0.7% | 31 |
|
|
2023
Q2 | $2.45M | Sell |
18,183
-56
| -0.3% | -$8.21K | 0.62% | 37 |
|
|
2023
Q1 | $2.91M | Sell |
18,239
-144
| -0.8% | -$22K | 0.77% | 23 |
|
|
2022
Q4 | $2.97M | Buy |
18,383
+344
| +2% | +$52.7K | 0.83% | 19 |
|
|
2022
Q3 | $2.42M | Sell |
18,039
-138
| -0.8% | -$19.8K | 0.89% | 23 |
|
|
2022
Q2 | $2.78M | Sell |
18,177
-9,748
| -35% | -$1.49M | 0.91% | 22 |
|
|
2022
Q1 | $4.53M | Sell |
27,925
-2,201
| -7% | -$320K | 1.39% | 13 |
|
|
2021
Q4 | $4.08M | Buy |
30,126
+210
| +0.7% | +$24.8K | 1.72% | 8 |
|
|
2021
Q3 | $3.23M | Buy |
29,916
+477
| +2% | +$54.5K | 1.47% | 8 |
|
|
2021
Q2 | $3.32M | Buy |
29,439
+31
| +0.1% | +$3.49K | 1.6% | 7 |
|
|
2021
Q1 | $3.18M | Buy |
29,408
+668
| +2% | +$71.5K | 1.6% | 8 |
|
|
2020
Q4 | $3.08M | Sell |
28,740
-308
| -1% | -$29.6K | 1.95% | 5 |
|
|
2020
Q3 | $2.54M | Sell |
29,048
-2,571
| -8% | -$242K | 1.69% | 8 |
|
|
2020
Q2 | $3.1M | Sell |
31,619
-3,644
| -10% | -$321K | 2.34% | 4 |
|
|
2020
Q1 | $2.69M | Buy |
35,263
+1,338
| +4% | +$114K | 2.42% | 6 |
|
|
2019
Q4 | $3M | Buy |
33,925
+2,376
| +8% | +$197K | 2.19% | 3 |
|
|
2019
Q3 | $2.39M | Buy |
31,549
+3,521
| +13% | +$241K | 1.8% | 8 |
|
|
2019
Q2 | $2.04M | Buy |
28,028
+2,127
| +8% | +$167K | 1.62% | 13 |
|
|
2019
Q1 | $2.09M | Buy |
25,901
+2,688
| +12% | +$220K | 1.63% | 9 |
|
|
2018
Q4 | $2.14M | Buy |
23,213
+11,181
| +93% | +$983K | 1.82% | 6 |
|
|
2018
Q3 | $1.16M | Buy |
12,032
+292
| +2% | +$27.7K | 0.87% | 38 |
|
|
2018
Q2 | $1.09M | Sell |
11,740
-5,716
| -33% | -$558K | 0.83% | 38 |
|
|
2018
Q1 | $1.65M | Sell |
17,456
-5,049
| -22% | -$555K | 1.33% | 18 |
|
|
2017
Q4 | $2.18M | Sell |
22,505
-14,913
| -40% | -$1.41M | 1.71% | 11 |
|
|
2017
Q3 | $3.32M | Sell |
37,418
-251
| -0.7% | -$19.1K | 2.71% | 2 |
|
|
2017
Q2 | $2.73M | Buy |
37,669
+761
| +2% | +$51.2K | 2.31% | 3 |
|
|
2017
Q1 | $2.4M | Buy |
36,908
+3,738
| +11% | +$235K | 2.08% | 6 |
|
|
2016
Q4 | $2.08M | Buy |
+33,170
| New | +$2.02M | 1.9% | 7 |
|
Other funds holding ABBV
First Bank & Trust's ABBV Position: Q2 2026 in Review
First Bank & Trust increased its AbbVie (ABBV) stake by 3.1% in Q2 2026, buying an estimated $135K and bringing the position to 20,753 shares worth $5.22M. The position accounts for 0.77% of the portfolio, ranked #26.
First Bank & Trust first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- First Bank & Trust held 20,753 shares of AbbVie worth $5.22M as of Q2 2026.
- First Bank & Trust bought 626 AbbVie shares in Q2 2026, an estimated $135K.
- AbbVie made up 0.77% of First Bank & Trust's portfolio in Q2 2026, its #26 holding.
- First Bank & Trust first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.